SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales figure stood at Rs. 3387.99 millions for the June 2022 quarter. The mentioned figure indicates a growth of about 28.43% as compared to Rs. 2638.01 millions during the year-ago period.Good  Net Profit growth of 40.04% reported above the corresponding previous quarter figure of Rs. 814.41 millions to Rs. 1140.51 millioins.The company reported a good operating profit of 1656.37 millions compared to 1203.99 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202206 202106 % Var 202206 202106 % Var 202203 202103 % Var
Sales 3387.99 2638.01 28.43 3387.99 2638.01 28.43 13202.22 10097.19 30.75
Other Income 108.98 57.83 88.45 108.98 57.83 88.45 1877.88 142.37 1219.01
PBIDT 1656.37 1203.99 37.57 1656.37 1203.99 37.57 7677.76 4547.59 68.83
Interest 14.33 21.26 -32.60 14.33 21.26 -32.60 62.31 91.44 -31.86
PBDT 1642.04 1182.73 38.83 1642.04 1182.73 38.83 7615.45 4456.15 70.90
Depreciation 105.48 89.93 17.29 105.48 89.93 17.29 390.97 316.36 23.58
PBT 1536.56 1092.80 40.61 1536.56 1092.80 40.61 7224.48 4139.79 74.51
TAX 396.05 278.39 42.26 396.05 278.39 42.26 1643.49 1053.32 56.03
Deferred Tax 7.24 6.76 7.10 7.24 6.76 7.10 67.19 36.17 85.76
PAT 1140.51 814.41 40.04 1140.51 814.41 40.04 5580.99 3086.47 80.82
Equity 254.57 254.57 0.00 254.57 254.57 0.00 254.57 254.57 0.00
PBIDTM(%) 48.89 45.64 7.12 48.89 45.64 7.12 58.16 45.04 29.12

Cohance Lifesciences Share Price

363.25 6.35 (1.78%)
16-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1693.15
Dr. Reddys Lab 1221.25
Cipla 1230.75
Zydus Lifesciences 939.20
Lupin 2326.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×